HealthTree Logo
search more_vert
person Sign In / Create Account
Salt Lake City October 15, 2022 Myeloma Round Table
Salt Lake City October 15, 2022 Myeloma Round Table image
HealthTree Roundtables for Multiple Myeloma
event Oct 15, 2022 / 09:00AM - 03:00PM MDT

Event Description

Learn from these top myeloma experts about the latest research and treatment to find out what you can do to stay one step ahead for your best outcomes.  Extensive time for audience questions is included in every Round Table.

Thanks to our Round Table sponsors

Event Summary

Myeloma Round Table: Engaging Myeloma Patients in Their Treatment — Salt Lake City, October 15, 2022, Session One


Douglas Sborov, MD, MS, Huntman Cancer Institute, University of Utah, Salt Lake City, UT: Becoming a Partner with Your Healthcare Team


Craig Hofmeister, MD, Winship Cancer Institute, Emory University, Atlanta, GA: Standard Treatment, Common Side Effects


Natalie Callander, MD, University of Wisconsin at Madison: What’s Next for Relapsed Myeloma?


Moderated Discussion: HealthTree CureHub: The Revolution Around the Corner?


Moderated Discussion/Audience Questions & Answers: Session One


Myeloma Round Table: Thinking Proactively About the Future — Salt Lake City, October 15, 2022, Session Two


Manni Mohyuddin, MBBS, Huntman Cancer Institute, University of Utah, Salt Lake City, UT: What Might Be Over the Horizon?


Krisstina Gown, DO, University of Arizona Cancer Center, Tuscon, AZ: It’s Not Just About Myeloma


Douglas Sborov Lead Faculty Discussion


Audience Questions & Answers: Session Two


Schedule & Agenda


Speakers & Moderators

The panelist Ghulam (Manni) Mohyuddin, MD
Ghulam (Manni) Mohyuddin, MD

Dr. Mohyuddin completed his medical training at the prestigious Aga Khan University in Pakistan. He completed his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. After residency, he pursued Chief Residency at the University of Kansas, focusing on mechanisms of novel educational delivery and improving access to research for trainees. He completed his fellowship at the University of Kansas, developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods, end of life, cost-effective/evidence-based care and medical education. He enjoys the outdoors tremendously, and that drew him to life in Utah where he is currently an Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.

Read Bio
The panelist Douglas Sborov, MD
Douglas Sborov, MD

Dr. Douglas Sborov is an Assistant Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through the American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships and joining the Division of Hematology as a Clinical Instructor, he and his family were drawn back to the beauty of the Wasatch Front where he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program, an Associate Member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), and an active member of the HCI Protocol Review and Monitoring Committee.

Read Bio
The panelist Craig Hofmeister
Craig Hofmeister

Craig C. Hofmeister, MD, MPH, is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.

Read Bio
The panelist Natalie Callander, MD
Natalie Callander, MD

Natalie Callander, MD joined the section of Hematology/Bone Marrow Transplant at the University of Wisconsin in October 2004 as an Associate Professor in the Department of Medicine. Dr. Callander graduated from Tufts University School of Medicine in Boston, MA, has completed residency at Bellevue Hospital in New York, as well as a Hematology/Oncology fellowship at the University of California-San Diego. Her board certifications include hematology, internal medicine, and medical oncology.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook twitter